OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
RCAR
RenovaCare, Inc.
Common Stock
Warning! This security is eligible for Unsolicited Quotes Only
This stock is not eligible for proprietary broker-dealer quotations. All quotes in this stock reflect unsolicited customer orders. Unsolicited-Only stocks have a higher risk of wider spreads, increased volatility, and price dislocations. Investors may have difficulty selling this stock. An initial review by a broker-dealer under SEC Rule15c2-11 is required for brokers to publish competing quotes and provide continuous market making.Warning! This security is traded on the Expert Market
The Expert Market® serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing. OTC Markets Group may designate securities for quoting on the Expert Market when it is not able to confirm that the company is making current information publicly available under SEC Rule 15c2-11, or when the security is otherwise restricted from public quoting. See additional information about the Expert Market here.N/A
N/A
N/A
N/A
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
ETRF | 24.90 | >year | |
CDEL | 21.92 | 03/16 | |
MACM | 18.95 | >year | |
NITE | 18.95 | >year | |
CSTI | 18.55 | >year |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
INTL | 19.40 | >year | |
NITE | 19.40 | >year | |
MACM | 19.43 | >year | |
MAXM | 20.11 | >year | |
CANT | 22.05 | >year |
No Real Time Level 2 Quotes Available on Expert Tier
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 04/25/2025 | 13:52:32 | 0.000001 | 0.00 | 500 |
| 04/25/2025 | 11:16:15 | 0.000001 | 0.00 | 200 |
| 04/10/2025 | 15:40:24 | 0.000001 | 0.00 | 500 |
| 04/09/2025 | 14:36:07 | 0.000001 | 0.00 | 475 |
| 04/09/2025 | 14:36:07 | 0.000001 | 0.00 | 700 |
News
SEC Litigation ReleaseOTC Disclosure & News Service | 05/28/2021
BCSC Revocation of Cease Trade OrderOTC Disclosure & News Service | 05/15/2019
BCSC Cease Trade OrderOTC Disclosure & News Service | 04/15/2019
Filings and Disclosure
Company Description
RenovaCare, Inc. is a development-stage biotechnology and medical device company focusing on the research, development and commercialization of autologous (using a patient's own cells) cellular therapies that can be used for medical and aesthetic applications. The Company does not have any commercialized products. We are currently developing and testing the CellMist System which is a cell isolation procedure that enzymatically renders stem cells from the patients own skin or other tissues. The resulting stem cell suspension is administered topically with our SkinGun spray device as a cell therapy onto wounds, including burns, to facilitate healing. On May 6, 2021 the Food and Drug Administration gave full-approval of the Company's Investigational Device Exemption (IDE) application to proceed with initial clinical testing of the CellMist System and SkinGun spray device in adult burn patients. The clinical trial protocol is an open-label, single-arm clinical study that is enrolling 14 adult human burn subjects with partial-thickness, second-degree deep thermal burn wounds covering between 10% and 30% total body surface area. The Company may engage up to four (4) U.S. burn centers to conduct the clinical study. Currently, the clinical trial is activated, enrolling and treating patients. The CELLMIST 1 clinical study is expected to reach completion in late 2022.
Videos
This company has not added any videos
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
51.15
Change
0.15 (0.29%)
Bid
N/A
Ask
N/A
Volume
13900
Time
15:59
